Skip to main content

Advertisement

SpringerLink
Log in

A Clinicopathologic Study of Head and Neck Malignant Peripheral Nerve Sheath Tumors

  • Original Paper
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

Abstract

Head and neck high grade malignant peripheral nerve sheath tumors (HN-MPNSTs) are rare highly aggressive soft tissue sarcomas that show overlapping morphologic and immunophenotypic features with melanoma and other high grade sarcomas, resulting in diagnostic challenges, particularly in sporadic settings. Recent discoveries have implicated loss of function mutations in the polycomb repressive complex 2 (PRC2) components, including EED or SUZ12 genes, as one of the leading pathogenetic mechanisms in high grade MPNST. MPNSTs with PRC2 loss are associated with complete loss of trimethylation at lysine 27 of histone H3 (H3K27me3), which emerged as a reliable immunohistochemical marker in the diagnosis of sporadic and radiation induced MPNST. As the diagnosis of MPNST in the HN is particularly challenging to distinguish from melanoma and other sarcoma types, we carried out a clinicopathologic analysis on HN-MPNST patients managed at our institution over a 20-year period (1997–2016), using the latest diagnostic criteria including H3K27me3 staining and other molecular investigations. The overall survival of HN-MPNST was compared with other HN soft tissue sarcomas. The diagnosis of HN-MPNST was confirmed in 13 patients (seven males and six females), with a mean age of 31 years; with 3 (23%) patients being of pediatric age. The most common site was the neck soft tissue (77%). Two-thirds of patients (n = 9) had stigmata of NF1, three had prior radiotherapy and only one developed a de novo MPNST. All except one tumor (86%) tested showed loss of H3K27me3 expression, including all non-NF1 patients. The 2 and 5-year DSS rates were 50 and 30%. The 2-year DFS rate was 21%. Adverse predictors on DSS included adult age (p = 0.011), prior-history of RT (p = 0.003) and recurrence (p = 0.003). Compared to other molecularly confirmed subsets of HN sarcomas (Ewing and Ewing-like sarcoma, rhabdomyosarcoma and synovial sarcoma), HN-MPNST had the worst overall survival (p < 0.0001). We conclude that HN-MPNSTs are highly aggressive sarcomas associated with an unfavorable outcome and the utility of H3K27me3 IHC stains in the evaluation of MPNST is a reliable ancillary diagnostic adjunct.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. WHO clasification of tumours of soft tissue and bone. Lyon: IARC Press; 2013. pp. 134–5.

    Google Scholar 

  2. Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer. 1986;57:2006–21.

    Article  PubMed  CAS  Google Scholar 

  3. Valentin T, Le Cesne A, Ray-Coquard I, Italiano A, Decanter G, Bompas E, et al. Management and prognosis of malignant peripheral nerve sheath tumors: the experience of the French Sarcoma Group (GSF-GETO). Eur J Cancer. 2016;56:77–84.

    Article  PubMed  CAS  Google Scholar 

  4. Patel TD, Shaigany K, Fang CH, Park RC, Baredes S, Eloy JA. Comparative analysis of head and neck and non-head and neck malignant peripheral nerve sheath tumors. Otolaryngology-head and neck surgery: official journal of American Academy of Otolaryngology-head and neck. Surgery. 2016;154:113–20.

    Google Scholar 

  5. Peng KA, Grogan T, Wang MB. Head and neck sarcomas: analysis of the SEER database. Otolaryngol–Head Neck Surg 2014;151:627–33.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Anghileri M, Miceli R, Fiore M, Mariani L, Ferrari A, Mussi C, et al. Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution. Cancer. 2006;107:1065–74.

    Article  PubMed  Google Scholar 

  7. Hrehorovich PA, Franke HR, Maximin S, Caracta P. Malignant peripheral nerve sheath tumor. Radiogr 2003;23:790–4.

    Article  Google Scholar 

  8. LaFemina J, Qin LX, Moraco NH, Antonescu CR, Fields RC, Crago AM, et al. Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors. Ann Surg Oncol. 2013;20:66–72.

    Article  PubMed  Google Scholar 

  9. Das Gupta TK, Brasfield RD. Solitary malignant schwannoma. Ann Surg. 1970;171:419–28.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Vege DS, Chinoy RF, Ganesh B, Parikh DM. Malignant peripheral nerve sheath tumors of the head and neck: a clinicopathological study. J Surg Oncol. 1994;55:100–3.

    Article  PubMed  CAS  Google Scholar 

  11. D’Agostino AN, Soule EH, Miller RH. Primary malignant neoplasms of nerves (malignant neurilemomas) in patients without manifestations of multiple neurofibromatosis (Von Recklinghausen’s disease). Cancer. 1963;16:1003–14.

    Article  PubMed  Google Scholar 

  12. Porter DE, Prasad V, Foster L, Dall GF, Birch R, Grimer RJ. Survival in malignant peripheral nerve sheath tumours: a comparison between sporadic and neurofibromatosis type 1-associated tumours. Sarcoma. 2009;2009:756395.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Wong WW, Hirose T, Scheithauer BW, Schild SE, Gunderson LL. Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys. 1998;42:351–60.

    Article  PubMed  CAS  Google Scholar 

  14. deCou JM, Rao BN, Parham DM, Lobe TE, Bowman L, Pappo AS, et al. Malignant peripheral nerve sheath tumors: the St. Jude Children’s Research Hospital experience. Ann Surg Oncol. 1995;2:524–9.

    Article  PubMed  CAS  Google Scholar 

  15. Zou C, Smith KD, Liu J, Lahat G, Myers S, Wang WL, et al. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome. Ann Surg. 2009;249:1014–22.

    Article  PubMed  Google Scholar 

  16. Ma C, Ow A, Shan OH, Wu Y, Zhang C, Sun J, et al. Malignant peripheral nerve sheath tumours in the head and neck region: retrospective analysis of clinicopathological features and treatment outcomes. Int J Oral Maxillofac Surg. 2014;43:924–32.

    Article  PubMed  CAS  Google Scholar 

  17. Arshi A, Tajudeen BA, St John M. Malignant peripheral nerve sheath tumors of the head and neck: demographics, clinicopathologic features, management, and treatment outcomes. Oral Oncol. 2015;51:1088–94.

    Article  PubMed  Google Scholar 

  18. Minovi A, Basten O, Hunter B, Draf W, Bockmuhl U. Malignant peripheral nerve sheath tumors of the head and neck: management of 10 cases and literature review. Head Neck. 2007;29:439–45.

    Article  PubMed  Google Scholar 

  19. Bahrami A, Folpe AL. Adult-type fibrosarcoma: a reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period. Am J Surg Pathol. 2010;34:1504–13.

    Article  PubMed  Google Scholar 

  20. Rodriguez FJ, Folpe AL, Giannini C, Perry A. Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems. Acta Neuropathol. 2012;123:295–319.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Nonaka D, Chiriboga L, Rubin BP. Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors. J Cutan Pathol. 2008;35:1014–9.

    Article  PubMed  Google Scholar 

  22. Nonaka D, Chiriboga L, Rubin BP. Sox10: a pan-schwannian and melanocytic marker. Am J Surg Pathol. 2008;32:1291–8.

    Article  PubMed  Google Scholar 

  23. Karamchandani JR, Nielsen TO, van de Rijn M, West RB. Sox10 and S100 in the diagnosis of soft-tissue neoplasms. Appl Immunohistochem Mol Morphol. 2012;20:445–50.

    Article  PubMed  CAS  Google Scholar 

  24. Miettinen M, McCue PA, Sarlomo-Rikala M, Biernat W, Czapiewski P, Kopczynski J, et al. Sox10–a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors. Am J Surg Pathol. 2015;39:826–35.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Scheithauer BW, Erdogan S, Rodriguez FJ, Burger PC, Woodruff JM, Kros JM, et al. Malignant peripheral nerve sheath tumors of cranial nerves and intracranial contents: a clinicopathologic study of 17 cases. Am J Surg Pathol. 2009;33:325–38.

    Article  PubMed  Google Scholar 

  26. Lee W, Teckie S, Wiesner T, Ran L, Prieto Granada CN, Lin M, et al. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. Nat Genet. 2014;46:1227–32.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  27. Zhang M, Wang Y, Jones S, Sausen M, McMahon K, Sharma R, et al. Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors. Nat Genet. 2014;46:1170–2.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. De Raedt T, Beert E, Pasmant E, Luscan A, Brems H, Ortonne N, et al. PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies. Nature. 2014;514:247–51.

    Article  PubMed  CAS  Google Scholar 

  29. Prieto-Granada CN, Wiesner T, Messina JL, Jungbluth AA, Chi P, Antonescu CR. Loss of H3K27me3 expression is a highly sensitive marker for sporadic and radiation-induced MPNST. Am J Surg Pathol. 2016;40:479–89.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Cleven AH, Sannaa GA, Briaire-de Bruijn I, Ingram DR, van de Rijn M, Rubin BP, et al. Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival. Mod Pathol. 2016;29:582–90.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Owosho AA, Estilo CL, Huryn JM, Zhang L, Fletcher CD, Antonescu CR. Head and neck round cell sarcomas: a comparative clinicopathologic analysis of 2 molecular subsets: ewing and CIC-rearranged sarcomas. Head Neck Pathol. 2017. doi:10.1007/s12105-017-0808-2.

  32. Antonescu CR, Owosho AA, Zhang L, Chen S, Deniz K, Huryn JM, et al. Sarcomas with CIC-rearrangements are a distinct pathologic entity with aggressive outcome: a clinicopathologic and molecular study of 115 cases. Am J Surg Pathol. 2017;41:941–49.

    Google Scholar 

  33. Owosho AA, Huang SC, Chen S, Kashikar S, Estilo CL, Wolden SL, et al. A clinicopathologic study of head and neck rhabdomyosarcomas showing FOXO1 fusion-positive alveolar and MYOD1-mutant sclerosing are associated with unfavorable outcome. Oral Oncol. 2016;61:89–97.

    Article  PubMed Central  Google Scholar 

  34. Owosho AA, Chen S, Kashikar S, Zhang L, Chen CL, Wexler LH, et al. Clinical and molecular heterogeneity of head and neck spindle cell and sclerosing rhabdomyosarcoma. Oral Oncol. 2016;58:e6–11.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  35. Owosho AA, Estilo CL, Rosen EB, Yom SK, Huryn JM, Antonescu CR. A clinicopathologic study on SS18 fusion positive head and neck synovial sarcomas. Oral Oncol. 2017;66:46–51.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Rohrich M, Koelsche C, Schrimpf D, Capper D, Sahm F, Kratz A, et al. Methylation-based classification of benign and malignant peripheral nerve sheath tumors. Acta Neuropathol. 2016;131:877–87.

    Article  PubMed  CAS  Google Scholar 

  37. Asano N, Yoshida A, Ichikawa H, Mori T, Nakamura M, Kawai A, et al. Immunohistochemistry for trimethylated H3K27 in the diagnosis of malignant peripheral nerve sheath tumours. Histopathology. 2017;70:385–93.

    Article  PubMed  Google Scholar 

  38. Schaefer IM, Fletcher CD, Hornick JL. Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics. Mod Pathol. 2016;29:4–13.

    Article  PubMed  CAS  Google Scholar 

  39. Pasmant E, Sohier P, Larousserie F. Synovial sarcomas do not show H3K27 trimethylation loss using immunohistochemistry. Am J Surg Pathol. 2017;41:283–5.

    Article  PubMed  Google Scholar 

  40. Gladdy RA, Qin LX, Moraco N, Edgar MA, Antonescu CR, Alektiar KM, et al. Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas? J Clin Oncol. 2010;28:2064–9.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Bishop AJ, Zagars GK, Torres KE, Bird JE, Feig BW, Guadagnolo BA. Malignant peripheral nerve sheath tumors: a single institution’s experience using combined surgery and radiation therapy. Am J Clin Oncol. 2016. doi:10.1097/COC.0000000000000303.

  42. Kroep JR, Ouali M, Gelderblom H, Le Cesne A, Dekker TJ, Van Glabbeke M, et al. First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study. Ann Oncol. 2011;22:207–14.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Supported in part by NIH/NCI Cancer Center Support Grant P50-CA140146-01 (CRA), Cycle for Survival (CRA); P30-CA008748, Kristen Ann Carr Foundation (CRA).

Author information

Authors and Affiliations

  1. College of Dental Medicine, University of New England, Portland, ME, 04103, USA

    Adepitan A. Owosho

  2. Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA

    Adepitan A. Owosho, Cherry L. Estilo & Joseph M. Huryn

  3. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA

    Ping Chi

  4. Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, USA

    Ping Chi

  5. Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA

    Cristina R. Antonescu

Authors
  1. Adepitan A. Owosho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cherry L. Estilo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joseph M. Huryn
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ping Chi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Cristina R. Antonescu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cristina R. Antonescu.

Ethics declarations

Conflicts of interest

All authors have contributed to this work and we declare that there are no financial conflicts associated with this study and that the funding source has no role in conceiving and performing the study.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed Consent

Not applicable.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Owosho, A.A., Estilo, C.L., Huryn, J.M. et al. A Clinicopathologic Study of Head and Neck Malignant Peripheral Nerve Sheath Tumors. Head and Neck Pathol 12, 151–159 (2018). https://doi.org/10.1007/s12105-017-0841-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-017-0841-y

Keywords

Search

Navigation